Pfizer Inc
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Hello and happy Tuesday! Today, we’re unpacking a shocking move from Pfizer. The pharmaceutical giant last week announced it […]
Read More
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where it can build a “unique position.” Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that deal with the secondary effects of […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. The Fed’s up Jerome Powell at Jackson Hole on August 23, 2024. David A. Grogan | CNBC The long-awaited Federal Reserve interest rate cut may finally arrive this week. The central bank’s policymakers are set to announce Wednesday whether they […]
Read More
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday. Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to […]
Read More
Investors are ignoring 2 big risks to markets, says CIO, naming stocks that are bond ‘substitutes’
Investors are ignoring two major risks to the market, according to Vahan Janjigian, chief investment officer at Greenwich Wealth Management. The first is the U.S. national debt, he told CNBC’s ” Street Signs Asia ” last week. “I think another major risk that investors are ignoring is the massive amount of debt in the United […]
Read More
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. […]
Read More
Check out these 11 U.S.-listed foreign stocks — which analysts give over 100% upside
A number of global stocks that trade in the U.S. have the potential to more than double over the next 12 months, according to average analyst price targets. CNBC Pro screened for U.S.-traded stocks of overseas-headquartered firms covered by 10 or more analysts. The table below lists 11 stocks that analysts give over 100% upside […]
Read More
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs […]
Read More
This water treatment startup is already a unicorn, and has $225 million in VC funding
While it might seem like humans and animals consume most of the world’s water, heavy industry uses up to half of it. That’s why business sectors are looking for new ways to recycle water, especially in the face of increased drought. Some of the world’s most essential industries, like pharmaceuticals, food and beverage, textiles, mining, […]
Read More
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans. […]
Read More